Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | +4,999,900.00% | -50.00% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Malesek
CEO | Chief Executive Officer | - | - |
James B. Smith
DFI | Director of Finance/CFO | - | 21-01-27 |
Charles Wagner
CHM | Chairman | - | 14-09-29 |
General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stefan Gruenwald
BRD | Director/Board Member | - | 19-10-07 |
Charles Wagner
CHM | Chairman | - | 14-09-29 |
Carlos Barnett
BRD | Director/Board Member | - | - |
Shawn Crouse
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,563,216 | 38,563,216 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Oncology Pharma, Inc.
One Sansome Street Suite 3500
94104, San Francisco
+415-869-1036
http://www.oncology-pharma.comSector
1st Jan change | Capi. | |
---|---|---|
-50.00% | 3.87K | |
+33.18% | 709B | |
+30.77% | 595B | |
-2.09% | 367B | |
+20.14% | 334B | |
+5.32% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.06% | 171B |
- Stock Market
- Equities
- ONPH Stock
- Company Oncology Pharma Inc.